TWC
ABCL icon

TD Waterhouse Canada’s AbCellera Biologics ABCL Stock Holding History

TD Waterhouse Canada’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.6M Buy
9,564,659
+9,542,247
+42,577% +$34.3M 0.1% 140
2025
Q4 		$76.4K Sell
22,412
-2,126
-9% -$9.49K ﹤0.01% 1096
2025
Q3 		$146K Buy
24,538
+1,185
+5% +$5.22K ﹤0.01% 943
2025
Q2 		$81.3K Sell
23,353
-87
-0.4% -$217 ﹤0.01% 1013
2025
Q1 		$48.7K Sell
23,440
-81,154
-78% -$233K ﹤0.01% 1096
2024
Q4 		$306K Sell
104,594
-127,830
-55% -$356K ﹤0.01% 714
2024
Q3 		$595K Sell
232,424
-13,180
-5% -$36.5K ﹤0.01% 585
2024
Q2 		$681K Sell
245,604
-12,718
-5% -$48.1K 0.01% 549
2024
Q1 		$1.13M Buy
258,322
+192
+0.1% +$980 0.01% 480
2023
Q4 		$1.58M Sell
258,130
-71,471
-22% -$331K 0.01% 358
2023
Q3 		$1.52M Sell
329,601
-244,314
-43% -$1.49M 0.02% 355
2023
Q2 		$4.24M Buy
573,915
+91,282
+19% +$623K 0.04% 230
2023
Q1 		$4.25M Sell
482,633
-30,931
-6% -$281K 0.04% 224
2022
Q4 		$5.77M Sell
513,564
-14,096
-3% -$163K 0.06% 182
2022
Q3 		$6.36M Buy
527,660
+173,184
+49% +$1.9M 0.07% 162
2022
Q2 		$4.55M Sell
354,476
-2,150
-0.6% -$18.2K 0.05% 208
2022
Q1 		$4.28M Buy
356,626
+175,671
+97% +$1.66M 0.04% 232
2021
Q4 		$2.84M Buy
+180,955
New +$2.75M 0.03% 309

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Waterhouse Canada's ABCL Position: Q1 2026 in Review

TD Waterhouse Canada increased its AbCellera Biologics (ABCL) stake by 42,577% in Q1 2026, buying an estimated $34.3M and bringing the position to 9,564,659 shares worth $33.6M. The position accounts for 0.1% of the portfolio, ranked #140.

TD Waterhouse Canada first reported a position in ABCL in Q4 2021 and has held it in 18 quarters since. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • TD Waterhouse Canada held 9,564,659 shares of AbCellera Biologics worth $33.6M as of Q1 2026.
  • TD Waterhouse Canada bought 9,542,247 AbCellera Biologics shares in Q1 2026, an estimated $34.3M.
  • AbCellera Biologics made up 0.1% of TD Waterhouse Canada's portfolio in Q1 2026, its #140 holding.
  • TD Waterhouse Canada first reported a position in AbCellera Biologics in Q4 2021 and has held it in 18 quarters since.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.